Clinical and Scientific Advisory Board

Michael Camilleri, M.D., Ph. D.
Dr. Michael Camilleri is a Professor of Physiology and Medicine at the Mayo Clinic, Minnesota, MN.  He has contributed extensively to the fields of enteric neurosciences, motility, and inflammatory bowel diseases (IBD).  Dr. Camilleri is on the editorial boards of a number of prestigious journals including Neurogastroenterology and Motility and American Neurogastroenterology. He has been President Elect of the American Neurogastroenterology and Motility Society 2007.

Lin Chang, M.D.
Dr. Lin Chang is a Professor of Medicine in the Division of Digestive Diseases and Department of Medicine at the David Geffen School of Medicine at UCLA. She is the Co-Director and Head of the Clinical Program at the Center for Neurovisceral Sciences & Women's Health and Director of the Women's Digestive Health Center at UCLA. Dr. Chang is the Co-chair of the Rome III subcommittee on Gender, Age and Cultural Influences on Functional Bowel Disorders. She is currently serving on the FDA GI Advisory Committee.

Douglas Drossman, M.D.
Dr. Douglas Drossman is a Professor of Medicine and Psychiatry, UNC School of Medicine, Division of Gastroenterology & Hepatology, and Co-Director of the UNC Center for Functional GI & Motility Disorders. He is President of the Rome Foundation and Scientific Director and member of the Board of the International Foundation for Functional GI Disorders (IFFGD). He has published extensively in the field of gastroenterology, including the textbook Functional GI Disorders (Rome I, Rome II and Rome III)

Scott Plevy, M.D.
Dr. Scott Plevy is an Associate Professor of Medicine, Microbiology and Immunology at the University of North Carolina School of Medicine, Division of Gastroenterology & Hepatology.  He is the Core Director of the Immunotechnology Core in the Center for Gastrointestinal Biology and Disease as well as the Director of the University of North Carolina Federation of Clinical Immunology Societies. Dr. Plevy has contributed significantly to the medical literature on Crohn’s disease and ulcerative colitis, and has been the principal investigator on numerous ulcerative colitis and Crohn’s disease clinical trials.

Dennis Riff, M.D.
Dr. Dennis Riff is board -certified in gastroenterology and internal medicine. He currently services as the Medical Director for the Advanced Clinical Research Institute in Anaheim, CA. Dr. Riff has contributed significantly to the medical literature in gastrointestinal disorders and has been the principal investigator on numerous gastrointestinal-related clinical trials.